The Nomination and Remuneration Committee (‘NRC’) set up by the Board is entrusted with combined advisory responsibilities concerning the nomination for appointment, reappointment or dismissal of directors and members of the Executive Committee and the remuneration policies and the individual remuneration of the directors and the members of the Executive Committee.
Christian Reinaudo, Chairman of the Nomination and Remuneration Committee – Permanent representative of CRBA Management BVBA
Frank Aranzana, Director of companies (independent director) – Permanent representative of Vantage Consulting BVBA
Line De Decker, Permanent representative of Albert House BV (independent director)
Christian Reinaudo (°1954 – French) is a graduate from the ‘Ecole de Physique et de Chimie Industrielles de Paris’ and holds a doctorate from the ‘University of Paris’ (France). He started his career with Alcatel (formerly named ‘Compagnie Générale d’Electricité’) in 1978 in the Research and Development Centre of Marcoussis (France). During his Alcatel period he managed several multi billion Euro businesses and international sales and services organizations. From 1984 to 1996, he held several positions in the Cable Group of Alcatel (now Nexans), from research and development, to manufacturing, procurement, sales support and services. He took the position of President of the Submarine Networks Division in early 1997. Appointed President of the whole Optics Group in 1999, he enters the Executive Committee of Alcatel early 2000 as Executive Vice-President. In 2003, he was appointed President of Alcatel Asia Pacific and moved to Shanghai (China) where he stayed until 2006. During this period he was also the Vice-Chairman of the Board of Directors of Alcatel Shanghai Bell, the Chinese joint venture of Alcatel with the Chinese government. In 2006, he came back to Paris to manage the integration and the transition process associated with the merger of Alcatel and Lucent Technologies. He also became Director in the Board of Directors of Draka Comteq (the Netherlands). In 2007, he was appointed President Northern and Eastern Europe of Alcatel-Lucent and he joined the Board of Directors of Alcatel-Lucent (Belgium). Early 2008, he joined Agfa-Gevaert to be President of Agfa HealthCare.
Christian Reinaudo joined the Agfa-Gevaert Board of Directors in 2010. From May 1, 2010 until January 31, 2020, he was CEO of Agfa-Gevaert.
Frank Aranzana (°1958 – French) holds a Bachelor’s degree in Economics and Political Sciences from IEP Paris, a Bachelor in Law from Nice University and later obtained a Master in Management from ESSEC Paris. He started his career in 1986 with Dow Chemical, where he worked in sales, marketing and Business management. In 1996, he joined DuPont Dow Elastomers as Business Director. In 1999, he joined UCB as a Director of the Radcure business unit and subsequently Specialty Chemicals, which were sold to Cytec Industries in 2005. He became Vice President of Cytec Surface Specialties and in 2008 President of Cytec Specialty Chemicals, member of Cytec’s Executive Leadership team and an Officer of Cytec Industries Inc. In 2013, he was appointed CEO of Allnex, the leading producer of coating resins acquired by Advent International Private Equity and in 2016, he became an Advent Operating partner, sitting on Allnex’s Advisory Committee.
Line De Decker
Line De Decker (°1974 – Belgian) is a senior executive with over 25 years of extensive experience operating at management board level in large, complex, regulated organizations. She combines her excellent communication, influencing and change management skills with an exceptional track record of leading businesses through critical transformations.
Mrs. De Decker holds a Law degree from the universities of Leuven and Barcelona, as well as a Master in Tax Management from Solvay Business School. She is the Chief People & Sustainability Officer and a member of the Executive Committee at Aliaxis, a world leader enabling access to water and energy through innovative fluid management solutions. Prior to joining Aliaxis, she was Senior Vice President and Head of Transformation at GlaxoSmithKline, where she led a global initiative aimed at transforming the company, creating new structures and processes fit for the future. Before taking up this role in the global strategy team, she held multiple senior HR roles in Belgium and the UK in the Corporate, Vaccines, Pharma and Consumer business. Prior to GSK, Mrs. De Decker worked at DuPont in Belgium and Spain, where she was involved in setting up their global business services. She started her career at PriceWaterhouseCoopers and UCB, as a tax and reward specialist.